NASDAQ:HSDT

Helius Medical Technologies News Headlines

$16.90
-0.22 (-1.29 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.55
Now: $16.90
$17.06
50-Day Range
$12.41
MA: $15.40
$18.45
52-Week Range
$9.45
Now: $16.90
$34.00
Volume24,518 shs
Average Volume134,469 shs
Market Capitalization$39.06 million
P/E RatioN/A
Dividend YieldN/A
Beta0.72

Headlines

Helius Medical Technologies (NASDAQ HSDT) News Headlines Today

SourceHeadline
Comparing Helius Medical Technologies (NASDAQ:HSDT) & Sonova (OTCMKTS:SONVY)Comparing Helius Medical Technologies (NASDAQ:HSDT) & Sonova (OTCMKTS:SONVY)
americanbankingnews.com - April 17 at 4:10 AM
Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21stHelius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st
finance.yahoo.com - April 15 at 9:06 AM
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Short Interest UpdateHelius Medical Technologies, Inc. (NASDAQ:HSDT) Short Interest Update
americanbankingnews.com - April 13 at 7:40 AM
Helius Medical Technologies (NASDAQ:HSDT) Earns Outperform Rating from Analysts at Noble FinancialHelius Medical Technologies (NASDAQ:HSDT) Earns Outperform Rating from Analysts at Noble Financial
americanbankingnews.com - March 30 at 9:44 AM
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ DeviceHelius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device
markets.businessinsider.com - March 29 at 6:42 AM
Noble Financial Initiates Coverage on Helius Medical Technologies (NASDAQ:HSDT)Noble Financial Initiates Coverage on Helius Medical Technologies (NASDAQ:HSDT)
americanbankingnews.com - March 24 at 10:08 AM
Helius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rdHelius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rd
finance.yahoo.com - March 17 at 5:42 PM
Helius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rdHelius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rd
finance.yahoo.com - March 17 at 5:42 PM
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2020 Results - Earnings Call TranscriptHelius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 12 at 2:34 PM
IIROC Trading Halt - HSMIIROC Trading Halt - HSM
finance.yahoo.com - January 28 at 9:31 AM
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At MarketHelius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market
finance.yahoo.com - January 28 at 9:31 AM
IIROC Trade Resumption - HSMIIROC Trade Resumption - HSM
finance.yahoo.com - January 28 at 9:31 AM
Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical DevicesHelius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices
finance.yahoo.com - January 20 at 8:06 AM
Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor ConferenceHelius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference
feeds.benzinga.com - January 15 at 12:54 PM
Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple SclerosisHelius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis
finance.yahoo.com - January 11 at 8:25 AM
Helius Medical Technologies, Inc. Comments on Unusual Market ActivityHelius Medical Technologies, Inc. Comments on Unusual Market Activity
finance.yahoo.com - January 5 at 6:37 PM
Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in JanuaryHelius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January
finance.yahoo.com - January 4 at 8:07 AM
Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in JanuaryHelius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January
benzinga.com - January 4 at 7:28 AM
Helius Medical Technologies, Inc. Announces Reverse Stock SplitHelius Medical Technologies, Inc. Announces Reverse Stock Split
finance.yahoo.com - December 31 at 7:28 AM
Helius Medical Technologies (HSDT) Management on Q3 2020 Results - Earnings Call TranscriptHelius Medical Technologies' (HSDT) Management on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 5:24 PM
Helius Medical Technologies EPS beats by $0.01, beats on revenueHelius Medical Technologies EPS beats by $0.01, beats on revenue
seekingalpha.com - November 12 at 8:12 PM
Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in NovemberHelius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November
finance.yahoo.com - November 5 at 7:49 AM
Helius Medical announces $3.4M private placementHelius Medical announces $3.4M private placement
seekingalpha.com - October 28 at 7:57 AM
Helius Medical Technologies Announces Closing of $3.4 Million Private PlacementHelius Medical Technologies Announces Closing of $3.4 Million Private Placement
finance.yahoo.com - October 26 at 6:28 PM
FDA has questions about Helius application for flagship medical device candidateFDA has questions about Helius application for flagship medical device candidate
bizjournals.com - October 21 at 11:14 AM
Helius Medical rallies on FDA progress on PoNS device applicationHelius Medical rallies on FDA progress on PoNS device application
seekingalpha.com - October 19 at 6:46 PM
Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple SclerosisHelius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis
finance.yahoo.com - October 19 at 6:46 PM
Helius Medical teams up with Breakthrough Health for multiple sclerosis insightsHelius Medical teams up with Breakthrough Health for multiple sclerosis insights
seekingalpha.com - October 14 at 8:44 AM
Helius Medical Technologies, Inc. Announces Partnership with Breakthrough Health for Multiple Sclerosis InsightsHelius Medical Technologies, Inc. Announces Partnership with Breakthrough Health for Multiple Sclerosis Insights
markets.businessinsider.com - October 14 at 7:16 AM
Helius Medical Technologies, Inc. Announces Publication of Peer-Reviewed Study: Translingual Neural Stimulation with the Portable Neuromodulation Stimulator (PoNS™) Induces Structural Changes Leading to Functional Recovery in Patients with Mild-to-Moderate Traumatic Brain InjuryHelius Medical Technologies, Inc. Announces Publication of Peer-Reviewed Study: Translingual Neural Stimulation with the Portable Neuromodulation Stimulator (PoNS™) Induces Structural Changes Leading to Functional Recovery in Patients with Mild-to-Moderate Traumatic Brain Injury
finance.yahoo.com - September 8 at 8:11 AM
Helius Medical Technologies EPS beats by $0.04, beats on revenueHelius Medical Technologies EPS beats by $0.04, beats on revenue
seekingalpha.com - August 12 at 5:00 PM
Helius Medical Technologies, Inc. Reports Second Quarter of Fiscal Year 2020 Financial ResultsHelius Medical Technologies, Inc. Reports Second Quarter of Fiscal Year 2020 Financial Results
finance.yahoo.com - August 12 at 5:00 PM
Helius Medical Technologies, Inc. (HSDT) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseHelius Medical Technologies, Inc. (HSDT) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - August 6 at 2:05 PM
Helius Medical Technologies Announces the Dismissal of the Shareholder Class Action LawsuitHelius Medical Technologies Announces the Dismissal of the Shareholder Class Action Lawsuit
finance.yahoo.com - July 14 at 8:46 AM
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Helius Medical Technologies, Inc. for Potential Breach of Fiduciary Duty ClaimsINVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Helius Medical Technologies, Inc. for Potential Breach of Fiduciary Duty Claims
finance.yahoo.com - June 15 at 10:08 AM
Helius Medical Technologies to Present at the Virtual Summer Summit on June 9thHelius Medical Technologies to Present at the Virtual Summer Summit on June 9th
www.benzinga.com - June 5 at 7:31 AM
Helius Medical Technologies to Present at the Virtual Summer Summit on June 9thHelius Medical Technologies to Present at the Virtual Summer Summit on June 9th
finance.yahoo.com - June 5 at 7:31 AM
Helius Medical Technologies, Inc. - Class AHelius Medical Technologies, Inc. - Class A
www.benzinga.com - May 23 at 11:18 PM
Helius Medical rockets 70% on Breakthrough Device tag for PoNS deviceHelius Medical rockets 70% on Breakthrough Device tag for PoNS device
seekingalpha.com - May 12 at 5:50 PM
Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple SclerosisHelius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis
finance.yahoo.com - May 12 at 7:33 AM
Helius Medical Technologies EPS beats by $0.01, misses on revenueHelius Medical Technologies EPS beats by $0.01, misses on revenue
seekingalpha.com - May 8 at 12:04 AM
Before You Buy Helius Medical Technologies, Inc. (NASDAQ:HSDT), Consider Its VolatilityBefore You Buy Helius Medical Technologies, Inc. (NASDAQ:HSDT), Consider Its Volatility
finance.yahoo.com - May 4 at 4:58 PM
Helius Medical Technologies, Inc. Announces Publication of its PoNS™ Registrational Clinical Trial (TBI-001) in TBIHelius Medical Technologies, Inc. Announces Publication of its PoNS™ Registrational Clinical Trial (TBI-001) in TBI
finance.yahoo.com - April 30 at 4:40 PM
BRIEF-Helius Medical Technologies Receives Letter From Nasdaq Indicating That Co No Longer Meets Minimum Bid Price Requirement - SEC FilingBRIEF-Helius Medical Technologies Receives Letter From Nasdaq Indicating That Co No Longer Meets Minimum Bid Price Requirement - SEC Filing
www.reuters.com - March 27 at 6:04 PM
BRIEF-Helius Medical Technologies Announces Authorization From Health Canada To Market The Pons™ DeviceBRIEF-Helius Medical Technologies Announces Authorization From Health Canada To Market The Pons™ Device
www.reuters.com - March 25 at 12:23 AM
Helius Medical Technologies Announces $2.2 Million Registered Direct OfferingHelius Medical Technologies Announces $2.2 Million Registered Direct Offering
finance.yahoo.com - March 18 at 8:20 AM
Can Helius Medical Technologies (NASDAQ:HSDT) Fund Its Growth Plans?Can Helius Medical Technologies (NASDAQ:HSDT) Fund Its Growth Plans?
finance.yahoo.com - March 15 at 2:17 PM
Helius Medical Technologies EPS beats by $0.02, misses on revenueHelius Medical Technologies EPS beats by $0.02, misses on revenue
seekingalpha.com - March 12 at 7:38 PM
BRIEF-Helius Medical Technologies Says Preliminary Revenue For Q4 Of 2019 Was About $0.1 MillionBRIEF-Helius Medical Technologies Says Preliminary Revenue For Q4 Of 2019 Was About $0.1 Million
in.reuters.com - March 2 at 2:06 PM
Helius Medical Technologies Reports Preliminary Unaudited Fourth Quarter and Full Year Unaudited 2019 Financial Results, Provides Commercial and Regulatory Update and Announces Submission to Health Canada for Multiple Sclerosis (MS) Label Expansion and New US Regulatory Prioritization for MSHelius Medical Technologies Reports Preliminary Unaudited Fourth Quarter and Full Year Unaudited 2019 Financial Results, Provides Commercial and Regulatory Update and Announces Submission to Health Canada for Multiple Sclerosis (MS) Label Expansion and New US Regulatory Prioritization for MS
finance.yahoo.com - March 2 at 9:05 AM
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.